» Articles » PMID: 34073785

Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome

Overview
Journal Nutrients
Date 2021 Jun 2
PMID 34073785
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Breastfeeding is associated with numerous health benefits, but early life nutrition has not been specifically studied in the neurodevelopmental disorder fragile X syndrome (FXS). Herein, I evaluate associations between the consumption of breast milk during infancy and the prevalence of autism, allergies, diabetes, gastrointestinal (GI) problems and seizures in FXS. The study design was a retrospective survey of families enrolled in the Fragile X Online Registry and Accessible Research Database (FORWARD). There was a 1.7-fold reduction in the prevalence of autism in FXS participants who were fed breast milk for 12 months or longer. There were strong negative correlations between increased time the infant was fed breast milk and the prevalence of autism and seizures and moderate negative correlations with the prevalence of GI problems and allergies. However, participants reporting GI problems or allergies commenced these comorbidities significantly earlier than those not fed breast milk. Parsing the data by sex indicated that males exclusively fed breast milk exhibited decreased prevalence of GI problems and allergies. These data suggest that long-term or exclusive use of breast milk is associated with reduced prevalence of key comorbidities in FXS, although breast milk is associated with the earlier development of GI problems and allergies.

Citing Articles

The Breastfeeding Experiences of Mother-Infant Dyads and the Effects of an FMR1 Mutation.

Cheves E, Potter S, Kutsa O, Andrews S, Gwaltney A, Wheeler A J Autism Dev Disord. 2024; .

PMID: 39586999 DOI: 10.1007/s10803-024-06644-4.


Bibliometric Analysis and a Call for Increased Rigor in Citing Scientific Literature: Folic Acid Fortification and Neural Tube Defect Risk as an Example.

Boeck B, Westmark C Nutrients. 2024; 16(15).

PMID: 39125384 PMC: 11313885. DOI: 10.3390/nu16152503.


Diet in treatment of autism spectrum disorders.

Alam S, Westmark C, McCullagh E Front Neurosci. 2023; 16:1031016.

PMID: 37492195 PMC: 10364988. DOI: 10.3389/fnins.2022.1031016.


Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model.

Westmark C, Filon M, Maina P, Steinberg L, Ikonomidou C, Westmark P Cells. 2022; 11(8).

PMID: 35456030 PMC: 9025435. DOI: 10.3390/cells11081350.


Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome.

Bui T, Shatto J, Cuppens T, Droit A, Bolduc F Front Psychiatry. 2021; 12:730987.

PMID: 34733188 PMC: 8558248. DOI: 10.3389/fpsyt.2021.730987.


References
1.
Sherman S, Kidd S, Riley C, Berry-Kravis E, Andrews H, Miller R . FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome. Pediatrics. 2017; 139(Suppl 3):S183-S193. PMC: 5621599. DOI: 10.1542/peds.2016-1159E. View

2.
Wise T . Changes in insulin-like growth factor signaling alter phenotypes in Fragile X Mice. Genes Brain Behav. 2016; 16(2):241-249. DOI: 10.1111/gbb.12340. View

3.
Westmark C . Soy Infant Formula may be Associated with Autistic Behaviors. Autism Open Access. 2014; 3. PMC: 4229689. DOI: 10.4172/2165-7890.1000120. View

4.
Winarni T, Chonchaiya W, Sumekar T, Ashwood P, Morales G, Tassone F . Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012; 158A(10):2473-81. PMC: 4105154. DOI: 10.1002/ajmg.a.35569. View

5.
Riikonen R, Makkonen I, Vanhala R, Turpeinen U, Kuikka J, Kokki H . Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev Med Child Neurol. 2006; 48(9):751-5. DOI: 10.1017/S0012162206001605. View